abstract |
(57) [Problem] To provide an excellent therapeutic agent for Meniere's disease or Meniere's syndrome, dizziness, hearing loss or tinnitus. The novel 1,4 represented by the general formula (I) A medicament comprising a 5,6-tetrahydroimidazo [4,5-d] benzazepine derivative or a pharmaceutically acceptable salt thereof as an active ingredient. [Formula] (Wherein ring D is phenylene or pyridinediyl, X and Y are the same or different and CH or N, R 1 , R 2 and R 3 is the same or different and represents a hydrogen atom, a hydroxyl group, a halogen or a lower alkyl. ) |